Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2

V. Saraswat*, S. Norris, R. J. De Knegt, J. F. Sanchez Avila, M. Sonderup, E. Zuckerman, P. Arkkila, C. Stedman, S. Acharya, I. Aho, A. C. Anand, M. I. Andersson, V. Arendt, O. Baatarkhuu, K. Barclay, Z. Ben-Ari, C. Bergin, F. Bessone, S. Blach, N. BlokhinaC. R. Brunton, G. Choudhuri, V. Chulanov, L. Cisneros, E. A. Croes, Y. A. Dahgwahdorj, O. Dalgard, J. R. Daruich, N. R. Dashdorj, D. Davaadorj, M. De Vree, C. Estes, R. Flisiak, A. C. Gadano, E. Gane, W. Halota, A. Hatzakis, C. Henderson, P. Hoffmann, J. Hornell, D. Houlihan, S. Hrusovsky, P. Jarčuška, D. Kershenobich, K. Kostrzewska, P. Kristian, M. Leshno, Y. Lurie, A. Mahomed, N. Mamonova, N. Mendez-Sanchez, J. Mossong, E. Nurmukhametova, P. Nymadawa, M. Oltman, J. Oyunbileg, Ts Oyunsuren, G. Papatheodoridis, N. Pimenov, N. Prabdial-Sing, M. Prins, P. Puri, S. Radke, A. Rakhmanova, H. Razavi, K. Razavi-Shearer, H. W. Reesink, E. Ridruejo, R. Safadi, O. Sagalova, R. Sanduijav, I. Schréter, C. Seguin-Devaux, S. R. Shah, I. Shestakova, A. Shevaldin, O. Shibolet, S. Sokolov, K. Souliotis, C. W. Spearman, T. Staub, E. A. Strebkova, D. Struck, K. Tomasiewicz, L. Undram, A. J. Van Der Meer, D. Van Santen, I. Veldhuijzen, F. G. Villamil, S. Willemse, F. R. Zuure, M. O. Silva, V. Sypsa, E. Gower

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

89 Citations (Scopus)

Abstract

Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and mortality. In many countries, there is a lack of comprehensive epidemiological data that are crucial in implementing disease control measures as new treatment options become available. Published literature, unpublished data and expert consensus were used to determine key parameters, including prevalence, viremia, genotype and the number of patients diagnosed and treated. In this study of 15 countries, viremic prevalence ranged from 0.13% in the Netherlands to 2.91% in Russia. The largest viremic populations were in India (8 666 000 cases) and Russia (4 162 000 cases). In most countries, males had a higher rate of infections, likely due to higher rates of injection drug use (IDU). Estimates characterizing the infected population are critical to focus screening and treatment efforts as new therapeutic options become available.

Original languageEnglish
Pages (from-to)6-25
Number of pages20
JournalJournal of Viral Hepatitis
Volume22
Issue numbers1
DOIs
Publication statusPublished - 1 Jan 2015

Keywords

  • HCV
  • diagnosis
  • disease burden
  • epidemiology
  • hepatitis C
  • incidence
  • mortality
  • prevalence
  • treatment

Fingerprint

Dive into the research topics of 'Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 2'. Together they form a unique fingerprint.

Cite this